BIIB (biogen.com) Company Net Income

Official company branding of biogen.com (BIIB)

Biogen Inc. is scaling its neuropharmaceuticals through global partnerships and startup acquisitions. However, regulatory risks and clinical trial complexities are creating significant pressure. Simultaneously, the company is implementing an environmental strategy focused on production decarbonization. The company's aggregate financial result helps identify entry points, while 0.82 represents the current metric value, capturing the latest profit dynamics.

BIIB Biogen Company Net Income (07/04/2022 - 10/29/2026)

Financial and market metric breakdowns for Biogen (BIIB)

- stock value and consensus price forecast:
Market Price Biogen Idec|BIIB - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Biogen Idec|BIIB - Enterprise Value
- book capitalization indicators:
Net Assets per Share Biogen|BIIB - Company Book Value|Market-to-Book Ratio biogen.com|BIIB - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Ratio Biogen Inc.|BIIB - Long-Term Debt to Capital|Current Liabilities to Capital Biogen Inc|BIIB - Company Debts|Debt to Book Value Ratio Biogen Idec|BIIB - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Biogen|Interim Coverage Ratio biogen.com
- earnings and multiples data:
BIIB - Company Net Income
Basic company analysis:Biogen Idec
Original product of Biogen Inc.

Biogen Inc. (BIIB) profit represents the final net income after deducting all operating and tax expenses. Investors utilize this metric to assess real-time cash generation efficiency and capital protection. Analyzing the company's consolidated profit allows for the identification of hidden yield trends. In the case of Biogen Inc. (BIIB), the consolidated profit trend reflects the pressure of legacy products on margins. Rising costs associated with promoting new drugs are hindering profit recovery.

Key competitors

Company Net Income Neurocrine Corp (NBIX)|RGC (Regencell Bioscience) - Net Profit|Company Net Income AXSM|Net Profit ACAD|Net Financial Result Xenon Pharmaceuticals Inc.|Company Net Income Viking Pharma VKTX|Supernus Corp (SUPN) - Company Net Income|Catalyst Pharmaceuticals - Net Profit|Annual Net Income denalitherapeutics.com (DNLI)|HRMY: Net Profit|Company Net Income Biohaven Ltd (BHVN)|Company Net Income Amylyx|Company Profit TRVI (Trevi Corp)|Net Income PRAX (Praxis Precision Medicines)|AVXL (anavex.com) - Final Profit|Net Profit CBLL (CeriBell)|Net Financial Result Prothena Corp (PRTA)|ALEC - Company Net Income|ANNX (Annexon Biosciences Inc.) - Company Profit|OMER: Net Profit|Net Income neurogene.com|Net Income ACIU|Voyager Therapeutics Inc (VYGR) - Net Financial Result|Net Profit NMRA|Company Net Income SCLX (Scilex Holding Company, Inc.)|Net Profit TVGN (Tevogen Bio Holdings)|Net Financial Result Alpha Cognition Inc (ACOG)|Cognition Therapeutics - Net Profit|Net Financial Result Inhibikase Therapeutics Inc IKT|SAVA: Net Profit|ASRT (Assertio) - Company Net Income|Company Net Income Coya Therapeutics Inc|Company Profit VTGN (VistaGen Therapeutics Inc)|Net Profit OVID|ABOS - Company Net Income|CervoMed Inc - Net Income|Net Profit Alterity Therapeutics Ltd. ATHE|CLNN - Company Net Income|Final Profit PEPG (PepGen Inc.)|Jupiter Neurosciences Inc (JUNS) - Company Net Income|Company Net Income Relmada Therapeutics Inc (RLMD)|ANVS (Annovis Bio Corp) - Net Profit|Company Net Income GRCE|Net Profit AIFF|Net Financial Result anewmeds.com|Company Net Income NeuroSense Therapeutics Ltd. NRSN|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Company Net Income|MetaVia, Inc. - Net Profit|Annual Net Income NeurAxis Inc (NRXS)|HSDT: Net Profit|Company Net Income Passage Bio (PASG)|Company Net Income Neuphoria Therapeutics, Inc.|Company Profit NERV (Minerva Neurosciences Inc)|Net Income ATHA (Athira)|ADXN (Addex) - Final Profit|Net Profit ALZN (Alzamend Neuro)|Net Financial Result Cyclerion Therapeutics Inc. (CYCN)|PTIX - Company Net Income|KTTA (Pasithea Therapeutics) - Company Profit|CRGT: Net Profit|Net Income Avenue Therapeutics Inc|Net Income BCLI|caratherapeutics.com (CARA) - Net Financial Result|Net Profit CHRO|Company Net Income ELYM (eliemtx.com)|Net Profit ITCI (Intra-Cellular Therapies, Inc.)|Net Financial Result Longboard (LBPH)|Marinus Pharmaceuticals - Net Profit|Net Financial Result nkgenbiotech.com NKGN|NRBO: Net Profit|SAGE (Sage Therapeutics Inc.) - Company Net Income|Company Net Income Neurotrope|Company Profit TRVN (Trevena Inc)|Net Profit VIGL|WENA - Company Net Income|Cerevel Therapeutics, Inc. - Net Income